Literature DB >> 6643664

Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.

B M Gray, H C Dillon, D E Briles.   

Abstract

The pneumococci possess, in addition to type-specific capsular polysaccharides, a number of antigens common to the species. Antibodies to phosphocholine (PC), a major determinant of the C-carbohydrate, have been shown to protect mice from experimental pneumococcal infection, but little is known of the role of anti-PC antibodies in humans or the extent to which anti-PC levels are affected by carriage or infection. We examined 115 sera from 30 infants, who were followed prospectively from birth through 4 years of age, for the presence of immunoglobulin M antibody to PC, using a solid-phase radioimmunoassay method. Infants were found to develop antibody to PC in response to pneumococcal carriage and infection, and nearly all infants developed some antibody. Antibody levels increased with age. By using a regression model including both age and nasopharyngeal carriage of pneumococci, anti-PC levels were found to be highest after exposure to two or three different types of pneumococci; levels were highest soon after acquisition of pneumococci and declined thereafter.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643664      PMCID: PMC272849          DOI: 10.1128/jcm.18.5.1102-1107.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Biological properties of an immunogenic pneumococcal subcellular preparation.

Authors:  H C Thompson; T K Eisenstein
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children.

Authors:  F A Loda; A M Collier; W P Glezen; K Strangert; W A Clyde; F W Denny
Journal:  J Pediatr       Date:  1975-12       Impact factor: 4.406

3.  Specificity for phosphorylcholine of six murine myeloma proteins reactive with Pneumococcus C polysaccharide and beta-lipoprotein.

Authors:  M A Leon; N M Young
Journal:  Biochemistry       Date:  1971-04-13       Impact factor: 3.162

Review 4.  Antigen-binding myeloma proteins in mice.

Authors:  M Potter
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

5.  Pneumococcal vaccine: development and prospects.

Authors:  R Austrian
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

6.  Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.

Authors:  J Yother; C Forman; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

7.  A phosphorylcholine idiotype related to TEPC 15 in mice infected with Ascaris suum.

Authors:  A R Brown; C A Crandall
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

8.  Serotypes of Streptococcus pneumoniae causing disease.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

9.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life.

Authors:  B M Gray; G M Converse; H C Dillon
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Capsulation of pneumococcus with soluble C-like (Cs) polysaccharide. I. Biological and genetic properties of Cs pneumococcal strains.

Authors:  D L Bornstein; G Schiffman; H P Bernheimer; R Austrian
Journal:  J Exp Med       Date:  1968-12-01       Impact factor: 14.307

View more
  22 in total

1.  Pneumococcal antigens and serum antibody responses in experimentally induced sinusitis.

Authors:  K M Westrin; A Freijd; P Stierna
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  A thymus-independent (type 1) phosphorylcholine antigen isolated from Trichinella spiralis protects mice against pneumococcal infection.

Authors:  P L Lim; W F Choy
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

Review 4.  Glycan Reactive Natural Antibodies and Viral Immunity.

Authors:  J Stewart New; R Glenn King; John F Kearney
Journal:  Viral Immunol       Date:  2019-12-17       Impact factor: 2.257

Review 5.  Microbial modulation of host immunity with the small molecule phosphorylcholine.

Authors:  Sarah E Clark; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

6.  Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.

Authors:  J R Bosarge; J M Watt; D O McDaniel; E Swiatlo; L S McDaniel
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Determination of antibodies to pneumococcal C polysaccharide in patients with community-acquired pneumonia.

Authors:  H Holmberg; A Krook; A M Sjögren
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

8.  Monoclonal phosphorylcholine antibody binds to beta-lipoprotein from different animal species.

Authors:  U B Sørensen
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

9.  PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type.

Authors:  L S McDaniel; J S Sheffield; P Delucchi; D E Briles
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Human anti-phosphorylcholine antibodies share idiotopes and are self-binding.

Authors:  R Halpern; S V Kaveri; H Köhler
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.